Our seventh of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office.
This course includes a live Q&A session with faculty. Join the July 31, 2020 12:00 PM ET broadcast to be a part of the live Q&A session or post July 31 watch this program on-demand and receive 1.0 credit until August 31, 2021. View the Accreditation Statement/Credit tab for additional details.
Moderator: Jonathan D. Wasserman, MD
Faculty: Adina Alazraki, MD, FAAP, Steven G. Waguespack, MD, and Ari J. Wassner, MD
Learning Objectives:
To review the epidemiology of thyroid carcinoma in children with attention to those with advanced disease.
To highlight areas where the approach to distal disease in children may differ from that in adults.
To consider the role of tumour genomics in prognostication and treatment planning.
To discuss indications for and timing of systemic therapy for children with advanced disease.
Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/.
American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).